1 / 6

Pharmacovigilance Market, Size, Share, Company Profiles And Future Trends Forecast To 2026

The study also applies qualitative and quantitative methods to assess the annual and financial performance of the top vendors and insights from market leaders.<br>

shabaz
Download Presentation

Pharmacovigilance Market, Size, Share, Company Profiles And Future Trends Forecast To 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pharmacovigilance Market To Reach USD 11.54 Billion By 2026

  2. Market Summary According to the current analysis of Reports and Data, the global Pharmacovigilance market was valued at USD 4.33 billion in 2018 and is expected to reach USD 11.54 billion by the year 2026, at a CAGR of 13.1%. The safety concern of drug is now becoming the priority area of interest all across the world. It has opened the eyes of drug regulators as well as another regulatory body to establish a way to ensure drug safety concerns; previously, the issues were in shadow. The drug safety issues were globalized, strengthen, and systematized after the favorable regulatory scenario was established. Pharmacovigilance is the field of science and activities which is related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related concern. Therefore, the ultimate goal of this activity is to improve the safety and rationalize the use of medicines in healthcare, thereby improving patient care and public health in the healthcare field.

  3. Our Approach Market Summary Every drug is associated with beneficial as well as an undesirable or adverse effect. Adverse drug reactions (ADR) is a common clinical problem. The major focus of pharmacovigilance is on ADR and drug toxicity. According to the WHO, studies show that in developed countries, nearly 5% of hospitalized patients are admitted into hospital as a result of an ADR, and 6-10% of in-patients are expected to experience a serious ADR during hospitalization. The pharmacovigilance market consists of all types of adverse events reporting conducted during clinical trials in hospitals, pharmacies, and other healthcare sectors. Increasing demand for acceptance and adoption of outsourcing services by healthcare companies will stimulate pharmacovigilance market growth during the forecast period. Moreover, Outsourcing eliminates the risk of business overhead costs as well as the deployment of pharmacovigilance resources. Request for a sample of this research report @ https://www.reportsanddata.com/sample-enquiry-form/2253

  4. Our Approach Market Summary Key takeaways of the Pharmacovigilance market report has been enlisted below: A comprehensive overview of the competitive landscape of the Pharmacovigilance market that examines the market position of leading companies like Accenture, Clinquest Group B.V., Cognizant, Laboratory Corporation of America Holdings, IBM Corporation, ArisGlobal, ICON plc. Capgemini, ITClinical, IMD global, Foresight Group International AG, TAKE Solutions Ltd., PAREXEL International Corporation, BioClinica, Wipro Ltd., and United BioSource Corporation.have been studied elaborately in the study. A brief description of all manufacturers, products range, and product applications have been also been provided. The report underlines information pertaining to the leading organizations based on their market positions as well as revenue generated. The report also includes the companies’ reported profit margins and pricing structure.

  5. Our Approach Market Summary Clinical trial phase (Revenue, USD Million; 2016–2026) Pre-clinical Phase I Phase II Phase III Phase IV Service providers (Revenue, USD Million; 2016–2026) In-house Contract Outsourcing Order Now@ https://www.reportsanddata.com/checkout-form/2253

  6. Our Approach About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

More Related